Enbrel
Enbrel
Enbrel (pronounced /ˈɛnbrɛl/), also known as etanercept, is a biopharmaceutical medication used primarily to treat autoimmune diseases.
Etymology
The name "Enbrel" is derived from its generic name, etanercept, which itself is a combination of terms relating to its biological function. "Etan" is derived from the Greek word "etanos", meaning to cause death, and "ercept" is a contraction of "receptor", referring to the drug's mechanism of action as a tumor necrosis factor receptor (TNFR).
Usage
Enbrel is used in the treatment of several autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It works by inhibiting the activity of tumor necrosis factor (TNF), a substance in the body that causes inflammation.
Mechanism of Action
Enbrel is a TNF inhibitor, which means it works by blocking the action of TNF, a substance in the body that causes inflammation. By inhibiting TNF, Enbrel can reduce inflammation and slow the progression of disease in patients with autoimmune disorders.
Side Effects
Common side effects of Enbrel include injection site reactions, infections, and headaches. Serious side effects can include severe infections, nervous system problems, and blood disorders.
Related Terms
- Autoimmune disease
- Rheumatoid arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Plaque psoriasis
- Tumor necrosis factor
- TNF inhibitor
External links
- Medical encyclopedia article on Enbrel
- Wikipedia's article - Enbrel
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski